Product NDC: | 0173-0675 |
Proprietary Name: | MALARONE |
Non Proprietary Name: | atovaquone and proguanil hydrochloride |
Active Ingredient(s): | 250; 100 mg/1; mg/1 & nbsp; atovaquone and proguanil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0675 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021078 |
Marketing Category: | NDA |
Start Marketing Date: | 20000726 |
Package NDC: | 0173-0675-01 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0173-0675-01) |
NDC Code | 0173-0675-01 |
Proprietary Name | MALARONE |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0173-0675-01) |
Product NDC | 0173-0675 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | atovaquone and proguanil hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20000726 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
Strength Number | 250; 100 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |